Concepedia

Luis Moltó

LM

Statistics

Publications

17

Citations

602

H-Index

13

Active since

1991

Affiliations

Hospital Universitario Príncipe de Asturias(Current)

Cleveland Clinic

Universidad de Alcalá

Cerner (United States)

Cleveland Clinic Lerner College of Medicine

Luis Moltó is an author at Hospital Universitario Príncipe de Asturias specializing in medicine, tumor microenvironment, and cancer research.

Top concepts

Publications per year

1991–2023

17

Publications

17

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

Robert G. Uzzo, Patricia Rayman, Vladimir Kolenko et al. · PubMed · 1999 · 147 citations

, , +17

Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

Gheath Alatrash, Thomas E. Hutson, Luis Moltó et al. · Journal of Clinical Oncology · 2004 · 80 citations · Full text

Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas

Mark Thornton, Daisuke Kudo, Patricia Rayman et al. · The Journal of Immunology · 2004 · 52 citations · Full text

Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.

Ronald M. Bukowski, Patricia Rayman, Luis Moltó et al. · PubMed · 1999 · 43 citations

, , +18

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways

Tanya Das, Gaurisankar Sa, Ewa Paszkiewicz‐Kozik et al. · The Journal of Immunology · 2008 · 42 citations

1–5 of 17